If Hepalink wants more ownsership/control of the company they would probably not allow large amounts of warrants to expire just because their strike price is higher than the market price.  They must know that the SP is so thinly traded that you can't accumulate 9,226,722 RVX shares in the market without sending the SP above $5 in a real hurry.  JMHO.  It puzzles me that Hepalink didn't excercise these warrants, secure an increase in their control, and, at this critical and financially desperate time for the company, inject much needed funds into the company they already have an important stake in.   

So will they now let expire another 2.2 million warrants in the face of all this positive news rumbbling down the pipe and still struggling finances? It will be interesting to see.  The choice they have over the next few months are:

1) Do nothing and let expire the warrants -- not increasing nor helping their own company stake
2) Exercise the 2,239,897 warrants and inject a hugely needed $7.2 million into the company

If Hepa doesn't exercise I will take that as an indication that there are "issues" with our relationship with Hepa.  It makes sense that Don wants to avoid at all cost an increase of Hepa's stake, turning to anyone but for small financings, so perhaps this has caused a burning of a bridge so-to-speak.   
IDK, just odd that Hepa isn't being more helpful financially, or clinically for that matter advancing apabetalone in China.  They would probabloy be making billions by now if they had moved quickly on setting-up trials in China after the 'apabetalone for covid' findings.  A real opportunity was missed there.

Something just doesn't make sense unless there has been a major falling out.  Thoughts?